19
Oct
2005
iBalance, Inc. is developing an alternative to total knee replacement surgery. The answer…the company’s proprietary Axial Knee Realignment technology, it is an implantable guidance and support device. The patient benefits are fourfold: pain relief, restoration of function, return to full physical activity, and improved tissue regeneration. iBalance recently closed on their $8.24 million Series A [...]
19
Oct
2005
They Call You Lady Luck
Posted in Events
That does it for the ten BioWest 2005 venture showcase finalists. Beyond competing for the $10,000 prize awarded by Faegre & Benson is the priceless exposure to the venture world. With just about three weeks to go the pitches are being polished…remember, each company has only ten minutes for their presentation. Achieving a refined and [...]
18
Oct
2005
Dr. Alex Kohav founded Thinc Pharmaceuticals, Inc. to develop advanced therapeutics for diseases that currently have no effective treatment, like liver cancer or inflammatory bowel disease, or have an extremely difficult therapeutic procedure. The Company is identifying and in-licensing currently available innovative technologies from around the US and as a result has exclusively in-licensed a [...]
17
Oct
2005
MBC Pharma, Inc. is working to commercialize pharmaceutical technology invented by the late Prof. Marat Karpeisky and Professor H.B.F. Dixon. They were joined by H. Lee Sturgeon (Cortech co-founder) to form the company. MBC intends to establish the therapeutic potential of its vitamin B6-bisphosphonate family of compounds as new therapies for osteoporosis and complications arising [...]
14
Oct
2005
Lohocla Research Corp., is a development stage company focused on the therapy and diagnosis of pain, psychiatric and addictive disorders. The lead product, a patent protected novel compound, has demonstrated biological activity in animals for pain, anxiety and alcohol dependence. Preliminary toxicology and pharmacology studies indicate the compound (DCUK) will be orally effective and at [...]
12
Oct
2005
InViragen, LLC was formed by Dr. Dan Stinchcomb to identify promising Dengue and West Nile vaccine technologies. The business plan calls for the completion of preclinical and Phase 1 and 2 clinical development., the vaccines then will be licensed to major pharmaceutical companies for Phase 3 clinical studies, manufacturing and marketing in the US and [...]
11
Oct
2005
CytoLogic, Inc. is a development-stage company pursuing the commercialization of a novel biological treatment for cancer. CytoLogic’s lead technology, the patented UNLEASH™ Immunotherapy, uses a medical device – not a drug – to treat solid tumors. This new approach to cancer treatment was conceived by two of the company’s shareholders, Dr. Mark Howell and Leland [...]
10
Oct
2005
CeraPedics, LLC was founded in 2000 to commercialize a proprietary technology for osteosynthetic bone substitute products and implant coatings that employ the Company’s small peptide P-15™ technology to facilitate bony fusion in orthopedic procedures. P-15 is a synthetic peptide analogous to the cell-binding domain of Type-I collagen. P-15 products create an ideal environment for bone [...]
07
Oct
2005
Brotica: A Chemical Attraction
Posted in Uncategorized
Brotica, Inc. was established in 2002 by a team of six researchers from Colorado State University. Brotica’s objective is to develop environmentally friendly, non-chemical products that fill gaps that exist in modern insect control strategies. Currently, Brotica is developing, manufacturing and selling Interval33™, a patented termite attractant that can be used in conjunction with existing [...]
06
Oct
2005
BioCare Systems, Inc. was founded in 1999 by Sherry Fox and her late husband Joe Pecukonis, for the purpose of designing, developing and marketing innovative health-care devices that use deep-tissue light therapy to decrease pain, accelerate healing and improve quality of life. The company received FDA-clearance in 2004 to market its first non-surgical deep-tissue, infrared-light [...]
04
Oct
2005
ApopLogic Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products that target unique apoptotic cell death pathways found in tumor cells and proliferating lymphocytes. The Company was formed in the summer of 2005 to capitalize on the intellectual property of its Scientific Founders, Richard C. Duke and Donald Bellgrau. [...]
02
Oct
2005
In 2002, CU Professors Bob Sievers and John Carpenter, together with Dr. Brian Quinn, founded Aktiv-Dry, LLC. The purpose of the company is to commercialize the use of supercritical carbon dioxide to form micro- and nano-scale particles of thermally sensitive compounds. The pharmaceutical industry is creating a demand for fine dry powders of micron size [...]
02
Oct
2005
Meet You at BioWest 2005
Posted in Events
While at BioWest 2005, November 8th and 9th at the Colorado Convention Center, be certain to stop in at the Venture Showcase. Faegre & Benson is offering a $10,000 award to the best presenting company judged by a panel of national venture capitalists; including Tim Mills (Sanderling, CA), Chris Kersey (Cogene, TX), Teri Willey (Arch [...]
Life Science Deal Flow PARTNERS
-
